Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Pharm Res. 2014 Mar 19;31(9):2490–2502. doi: 10.1007/s11095-014-1345-z

Fig 2.

Fig 2

Schematic showing encapsulation of myrisplatin and C6-ceramide into lipid core of nanoemulsion and its surface is modified with gadolinium and EGFR binding peptide for MRI functionality and targeting, respectively.